MedPath

Effect of umbilical cord Wharton's jelly in treatment of melasma

Early Phase 1
Conditions
Melasma.
Registration Number
IRCT20180116038386N1
Lead Sponsor
Abadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
25
Inclusion Criteria

Pregnant mother with melasma

Exclusion Criteria

Another skin disease such as rash, acne, .....
Systemic disease with dermatological signs such as Hepatitis C Virus , Lupus Erythematosus, ....
Systemic steroid therapy
Exposure to direct sunlight

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Melasma. Timepoint: Before intervention and 6 weeks after intervention. Method of measurement: Melasma area severity index (MASI).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath